Company intelligence / Profile preview

Akili Interactive Labs, Inc.

Boston, Massachusetts, United Statesakiliinteractive.com ↗

Ownership: Public · AKLI
Development stage: Commercial

Overview

Akili has completed 20 clinical trials across 2,900 patients and nine disease populations. Their lead product EndeavorRx is FDA-cleared for pediatric ADHD ages 8-12. Recent clinical trials in adults with ADHD showed significant improvements in attention, with over 80% of adults showing improvement and one-third no longer exhibiting attention deficit after treatment. In Japan, Shionogi's Phase 3 trial of SDT-001 (Japanese version of EndeavorRx) showed positive results for pediatric ADHD patients aged 6-17.

Therapeutic areas: PsychiatryNeurology
Modalities: Digital therapeuticsSoftware-based interventionsVideo game-based therapeutics
Industry: Digital Health Medical Devices

Drug pipeline

2 assets

EndeavorRx

Commercial

Indications: ADHD in children

1 more asset in the full pipeline.

Request access →

Partnerships

Shionogi & Co., Ltd.Virtual Therapeutics

Financials

Market cap: $34.1M
Total revenue: $383K
Enterprise value: $-15.7M

Beyond the preview

Go deeper on Akili Interactive Labs, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akili Interactive Labs, Inc..

Explore the full profile